Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Riemsma R, Corro Ramos I, Birnie R, et al. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Feb. (Health Technology Assessment, No. 20.17.)
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Show detailsTABLE 85
Glycated haemoglobin conversion table: older DCCT-aligned (%) and newer IFCC-standardised (mmol/mol) concentrations (IFCC-standardised values are rounded to the nearest whole number)
| HbA1c ‘old’ | HbA1c ‘new’ | HbA1c ‘old’ | HbA1c ‘new’ |
|---|---|---|---|
| 4.0 | 20 | 9.1 | 76 |
| 4.1 | 21 | 9.2 | 77 |
| 4.2 | 22 | 9.3 | 78 |
| 4.3 | 23 | 9.4 | 79 |
| 4.4 | 25 | 9.5 | 80 |
| 4.5 | 26 | 9.6 | 81 |
| 4.6 | 27 | 9.7 | 83 |
| 4.7 | 28 | 9.8 | 84 |
| 4.8 | 29 | 9.9 | 85 |
| 4.9 | 30 | 10.0 | 86 |
| 5.0 | 31 | 10.1 | 87 |
| 5.1 | 32 | 10.2 | 88 |
| 5.2 | 33 | 10.3 | 89 |
| 5.3 | 34 | 10.4 | 90 |
| 5.4 | 36 | 10.5 | 91 |
| 5.5 | 37 | 10.6 | 92 |
| 5.6 | 38 | 10.7 | 93 |
| 5.7 | 39 | 10.8 | 95 |
| 5.8 | 40 | 10.9 | 96 |
| 5.9 | 41 | 11.0 | 97 |
| 6.0 | 42 | 11.1 | 98 |
| 6.1 | 43 | 11.2 | 99 |
| 6.2 | 44 | 11.3 | 100 |
| 6.3 | 45 | 11.4 | 101 |
| 6.4 | 46 | 11.5 | 102 |
| 6.5 | 48 | 11.6 | 103 |
| 6.6 | 49 | 11.7 | 104 |
| 6.7 | 50 | 11.8 | 105 |
| 6.8 | 51 | 11.9 | 107 |
| 6.9 | 52 | 12.0 | 108 |
| 7.0 | 53 | 13.0 | 119 |
| 7.1 | 54 | 13.1 | 120 |
| 7.2 | 55 | 13.2 | 121 |
| 7.3 | 56 | 13.3 | 122 |
| 7.4 | 57 | 13.4 | 123 |
| 7.5 | 58 | 13.5 | 124 |
| 7.6 | 60 | 13.6 | 125 |
| 7.7 | 61 | 13.7 | 126 |
| 7.8 | 62 | 13.8 | 127 |
| 7.9 | 63 | 13.9 | 128 |
| 8.0 | 64 | 14.0 | 130 |
| 8.1 | 65 | 14.1 | 131 |
| 8.2 | 66 | 14.2 | 132 |
| 8.3 | 67 | 14.3 | 133 |
| 8.4 | 68 | 14.4 | 134 |
| 8.5 | 69 | 14.5 | 135 |
| 8.6 | 70 | 14.6 | 136 |
| 8.7 | 72 | 14.7 | 137 |
| 8.8 | 73 | 14.8 | 138 |
| 8.9 | 74 | 14.9 | 139 |
| 9.0 | 75 |
IFCC, International Federation of Clinical Chemistry.
Definitions: ‘old’ unit = DCCT unit (%); ‘new’ unit = IFCC unit (mmol/mol).
Conversion formulas: ‘old’ = (0.0915 × ‘new’) + 2.15%; ‘new’ = (10.93 × ‘old’) – 23.5 mmol/mol.
TABLE 86
Glucose values conversion table (mg/dl to mmol/l)
| mg/dl to mmol/l | mmol/l to mg/dl | ||
|---|---|---|---|
| mg/dl | mmol/l | mmol/l | mg/dl |
| 40 | 2.2 | 2.0 | 36 |
| 45 | 2.5 | 2.5 | 45 |
| 50 | 2.8 | 3.0 | 54 |
| 55 | 3.1 | 3.5 | 63 |
| 60 | 3.3 | 4.0 | 72 |
| 65 | 3.6 | 4.5 | 81 |
| 70 | 3.9 | 5.0 | 90 |
| 75 | 4.2 | 5.5 | 99 |
| 80 | 4.4 | 6.0 | 108 |
| 85 | 4.7 | 6.5 | 117 |
| 90 | 5.0 | 7.0 | 126 |
| 95 | 5.3 | 7.5 | 135 |
| 100 | 5.6 | 8.0 | 144 |
| 110 | 6.2 | 8.5 | 153 |
| 120 | 6.7 | 9.0 | 162 |
| 130 | 7.2 | 9.5 | 171 |
| 140 | 7.8 | 10.0 | 180 |
| 150 | 8.3 | 10.5 | 189 |
| 160 | 8.9 | 11.0 | 198 |
| 170 | 9.4 | 11.5 | 207 |
| 180 | 10.0 | 12.0 | 216 |
| 190 | 10.6 | 12.5 | 225 |
| 200 | 11.1 | 13.0 | 234 |
| 220 | 12.2 | 13.5 | 243 |
| 240 | 13.3 | 14.0 | 252 |
| 260 | 14.4 | 14.5 | 261 |
| 280 | 15.5 | 15.0 | 270 |
| 300 | 16.7 | 16.0 | 288 |
| 320 | 17.8 | 17.0 | 306 |
| 340 | 18.9 | 18.0 | 324 |
| 360 | 20.0 | 19.0 | 342 |
| 380 | 21.1 | 20.0 | 360 |
| 400 | 22.2 | 21.0 | 378 |
| 420 | 23.3 | 22.0 | 396 |
| 440 | 24.4 | 23.0 | 414 |
| 460 | 25.5 | 24.0 | 432 |
Conversion formulas: mg/dl × 0.0555 = mmol/l; mmol/l × 18.018 = mg/dl.
- Conversion tables for glycated haemoglobin and glucose values - Integrated senso...Conversion tables for glycated haemoglobin and glucose values - Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
Your browsing activity is empty.
Activity recording is turned off.
See more...